External link

Ending discrimination against survivors through the Right to be Forgotten

The growing number of cancer survivors in the EU is a tribute to the success of advances in diagnosis and treatment. The latest scientific research and data account for over 20 million cancer survivors in Europe and, for many, it then becomes necessary to overcome the psychological impact of their treatments, workplace marginalization and access to financial services such as mortgages and loans. Thanks to

The opportunity for greater patient and public involvement and engagement in drug development and regulation – Members Only

Patients and the wider public are beneficiaries of scientific research that leads to new drugs and medical technologies, but they can and should be able to contribute to these advances through participation in clinical studies, co-design of research and input into regulatory processes. The key elements of PPIE, proposed by Kathy Oliver, patient advocate

Go to Top